Stock Analysis on Net
Stock Analysis on Net

AmerisourceBergen Corp. (NYSE:ABC)

This company has been moved to the archive! The financial data has not been updated since August 2, 2023.

Enterprise Value to EBITDA (EV/EBITDA)

Microsoft Excel

Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)

AmerisourceBergen Corp., EBITDA calculation

US$ in thousands

Microsoft Excel
12 months ended: Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Net income (loss) attributable to AmerisourceBergen Corporation 1,698,820 1,539,932 (3,408,716) 855,365 1,658,405 364,484
Add: Net income attributable to noncontrolling interest (32,280) 4,676 9,158 (1,230) (42,513) —
Add: Income tax expense 516,517 677,251 (1,894,273) 112,971 (438,469) 553,403
Earnings before tax (EBT) 2,183,057 2,221,859 (5,293,831) 967,106 1,177,423 917,887
Add: Interest expense 231,982 182,544 158,522 195,474 189,640 149,042
Earnings before interest and tax (EBIT) 2,415,039 2,404,403 (5,135,309) 1,162,580 1,367,063 1,066,929
Add: Depreciation, including amounts charged to cost of goods sold 390,643 326,713 290,744 321,102 318,483 262,420
Add: Amortization, including amounts charged to interest expense 319,192 188,073 117,269 176,410 191,626 169,911
Earnings before interest, tax, depreciation and amortization (EBITDA) 3,124,874 2,919,189 (4,727,296) 1,660,092 1,877,172 1,499,260

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).


The financial performance of AmerisourceBergen Corporation from 2017 to 2022 is characterized by a period of steady growth, a severe singular contraction in 2020, and a subsequent robust recovery. The trajectory across all earnings metrics—Net Income, EBT, EBIT, and EBITDA—shows a high degree of correlation, indicating that the primary drivers of profitability were systemic rather than related to specific financing or tax adjustments.

EBITDA Trend Analysis
Earnings before interest, tax, depreciation, and amortization exhibited growth in the early period, rising from US$ 1,499,260 thousand in 2017 to a peak of US$ 1,877,172 thousand in 2018. Following a slight decline in 2019 to US$ 1,660,092 thousand, a significant reversal occurred in 2020, where EBITDA fell to a deficit of US$ 4,727,296 thousand. However, a strong recovery followed, with EBITDA reaching US$ 2,919,189 thousand in 2021 and further increasing to US$ 3,124,874 thousand by 2022, marking the highest level in the analyzed six-year period.
Operating Profitability and Margin Volatility
Earnings before interest and tax (EBIT) mirrored the EBITDA trend, experiencing a drastic collapse in 2020 to negative US$ 5,135,309 thousand. The narrow gap between EBIT and EBITDA throughout the period suggests that depreciation and amortization expenses remained relatively stable, while the massive 2020 loss was driven by operational or non-recurring charges. By 2022, EBIT stabilized at US$ 2,415,039 thousand, indicating a return to operational efficiency that exceeded pre-2020 levels.
Net Income and Bottom-Line Performance
Net income demonstrated extreme volatility, fluctuating from a low of negative US$ 3,408,716 thousand in 2020 to US$ 1,698,820 thousand in 2022. The recovery from the 2020 deficit was rapid, with the corporation returning to profitability in 2021. The alignment between EBT and Net Income suggests that the 2020 impact was largely pre-tax in nature, and the subsequent recovery reflects a restoration of core earning capacity.

Overall, the data indicates that the organization successfully navigated a critical financial downturn in 2020. The growth observed in 2021 and 2022 not only erased the losses of the preceding year but established a new baseline for EBITDA and Net Income that surpasses the 2017-2019 average.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Enterprise Value to EBITDA Ratio, Current

AmerisourceBergen Corp., current EV/EBITDA calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in thousands)
Enterprise value (EV) 41,299,807
Earnings before interest, tax, depreciation and amortization (EBITDA) 3,124,874
Valuation Ratio
EV/EBITDA 13.22
Benchmarks
EV/EBITDA, Competitors1
Abbott Laboratories 15.14
Elevance Health Inc. 9.21
Intuitive Surgical Inc. 35.76
Medtronic PLC 14.26
UnitedHealth Group Inc. 17.84
EV/EBITDA, Sector
Health Care Equipment & Services 14.31
EV/EBITDA, Industry
Health Care 19.44

Based on: 10-K (reporting date: 2022-09-30).

1 Click competitor name to see calculations.

If the company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if the company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.


Enterprise Value to EBITDA Ratio, Historical

AmerisourceBergen Corp., historical EV/EBITDA calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Selected Financial Data (US$ in thousands)
Enterprise value (EV)1 36,473,156 30,235,610 20,514,111 18,995,014 20,769,340 18,335,740
Earnings before interest, tax, depreciation and amortization (EBITDA)2 3,124,874 2,919,189 (4,727,296) 1,660,092 1,877,172 1,499,260
Valuation Ratio
EV/EBITDA3 11.67 10.36 — 11.44 11.06 12.23
Benchmarks
EV/EBITDA, Competitors4
Abbott Laboratories 15.85 17.42 — — — —
Elevance Health Inc. 10.26 10.05 — — — —
Intuitive Surgical Inc. 40.96 44.10 — — — —
Medtronic PLC 14.99 24.41 — — — —
UnitedHealth Group Inc. 15.11 17.39 — — — —
EV/EBITDA, Sector
Health Care Equipment & Services 15.26 18.05 — — — —
EV/EBITDA, Industry
Health Care 14.00 14.33 — — — —

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

1 See details »

2 See details »

3 2022 Calculation
EV/EBITDA = EV ÷ EBITDA
= 36,473,156 ÷ 3,124,874 = 11.67

4 Click competitor name to see calculations.


The enterprise value (EV) demonstrates a significant long-term growth trajectory, increasing from 18.3 billion USD in 2017 to 36.5 billion USD by 2022. While the growth was moderate between 2017 and 2020, a sharp acceleration occurred after September 30, 2020, with the EV rising by approximately 78% over the final two years of the period.

EBITDA Performance and Volatility
Earnings before interest, tax, depreciation, and amortization exhibited substantial volatility. After growing to 1.88 billion USD in 2018, EBITDA plummeted to a negative 4.73 billion USD in 2020. This anomaly represents a severe disruption in operational profitability for that fiscal year. However, a robust recovery followed, with EBITDA returning to positive territory at 2.92 billion USD in 2021 and further increasing to 3.12 billion USD in 2022.
EV/EBITDA Ratio Stability
Despite the extreme fluctuations in underlying EBITDA and the rapid escalation of enterprise value, the EV/EBITDA ratio remained remarkably stable. Excluding the 2020 period where the ratio was not applicable due to negative earnings, the multiple fluctuated within a narrow range between 10.36 and 12.23. This suggests that the market valuation of the enterprise has largely expanded in tandem with its recovered earning capacity.
Valuation Trends
The ratio reached its peak in 2017 at 12.23 and hit its lowest point in 2021 at 10.36. The slight uptick to 11.67 in 2022 indicates a return toward historical valuation norms as the enterprise value continued to climb faster than the growth in EBITDA during the final year of the analyzed period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?